Centiva Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Sell
10,076
-8,628
-46% -$240K ﹤0.01% 1193
2026
Q1
$350K Sell
18,704
-8,796
-32% -$168K ﹤0.01% 988
2025
Q4
$635K Sell
27,500
-22,500
-45% -$580K 0.01% 655
2025
Q3
$1.34M Buy
+50,000
New +$1.19M 0.01% 442
2025
Q1
Sell
-22,368
Closed -$543K 2107
2024
Q4
$543K Buy
+22,368
New +$639K 0.01% 771
2024
Q1
Sell
-20,070
Closed -$626K 2232
2023
Q4
$626K Buy
+20,070
New +$721K 0.01% 848
2022
Q4
Sell
-4,657
Closed -$329K 1610
2022
Q3
$329K Buy
+4,657
New +$399K 0.01% 1015
2021
Q3
Sell
-1,850
Closed -$282K 1584
2021
Q2
$282K Sell
1,850
-11,054
-86% -$1.46M 0.01% 1069
2021
Q1
$1.36M Buy
12,904
+6,252
+94% +$626K 0.05% 258
2020
Q4
$527K Buy
+6,652
New +$487K 0.02% 446
2020
Q3
Sell
-8,229
Closed -$506K 866
2020
Q2
$506K Buy
+8,229
New +$336K 0.03% 286

Other funds holding STAA

Centiva Capital's STAA Position: Q2 2026 in Review

Centiva Capital reduced its STAAR Surgical (STAA) stake by 46% in Q2 2026, selling an estimated $240K and leaving 10,076 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Centiva Capital first reported a position in STAA in Q2 2020 and has held it in 11 quarters since. The position peaked at $1.36M in Q1 2021. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Centiva Capital held 10,076 shares of STAAR Surgical worth $289K as of Q2 2026.
  • Centiva Capital sold 8,628 STAAR Surgical shares in Q2 2026, an estimated $240K.
  • STAAR Surgical made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1193 holding.
  • Centiva Capital first reported a position in STAAR Surgical in Q2 2020 and has held it in 11 quarters since.
  • Centiva Capital's STAAR Surgical position peaked at $1.36M in Q1 2021.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.